A Deferasirox Derivative That Acts as a Multifaceted Platform for the Detection and Quantification of Fe<sup>3+</sup>
Here, we report that ExSO<sub>3</sub>H, a synthetically accessible, water-soluble, non-toxic derivative of the clinical iron chelator deferasirox, acts as a colorimetric chemosensor that permits the detection and quantification of Fe<sup>3+</sup> in aqueous samples at pH 2–5....
Main Authors: | Axel Steinbrueck, Adam C. Sedgwick, Suh-Mi Hwang, Sajal Sen, Michael Y. Zhao, Dan-Ying Huang, Daniel M. Knoll, Yu-Ying Wang, Jonathan L. Sessler |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Chemosensors |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9040/9/4/68 |
Similar Items
-
Modulation of the Immune Response by Deferasirox in Myelodysplastic Syndrome Patients
by: Hana Votavova, et al.
Published: (2021-01-01) -
Kidney Tubular Damage Secondary to Deferasirox: Systematic Literature Review
by: Martin Scoglio, et al.
Published: (2021-12-01) -
Comparison of the Mean Serum Ferritin Levels in Thalassaemia Major Patients after Giving Deferasirox and Deferoxamine
by: Seema Aftab, et al.
Published: (2017-12-01) -
LONG-TERM EFFECTIVENESS, SAFETY, AND TOLERABILITY OF TWICE-DAILY DOSING WITH DEFERASIROX IN CHILDREN WITH TRANSFUSION-DEPENDENT THALASSEMIAS UNRESPONSIVE TO STANDARD ONCE-DAILY DOSING
by: Jassada Buaboonnam, et al.
Published: (2021-10-01) -
Antioxidant Activity of Deferasirox and Its Metal Complexes in Model Systems of Oxidative Damage: Comparison with Deferiprone
by: Viktor A. Timoshnikov, et al.
Published: (2021-08-01)